Development of a HPLC-DAD Method for the Simultaneous Quantification of 5-O-β-D-galactopyranosyl-7-methoxy-3’,4’-dihydroxy-4-phenylcoumarin and its Aglycone in Feces

Authors

  • Sol Cristians Universidad Nacional Autónoma de México
  • Kenneth Rubio-Carrasco Universidad Nacional Autónoma de México
  • Angélica Soledad Díaz-Juárez Universidad Nacional Autónoma de México
  • Vannesa González-Covarrubias Instituto Nacional de Medicina Genómica
  • Inés Fuentes-Noriega Universidad Nacional Autónoma de México

DOI:

https://doi.org/10.29356/jmcs.v60i3.93

Keywords:

4-phenylcoumarin, aglycone, Copalchi, HPLC-DAD, pharmacokinetic.

Abstract

A sensitive and specific HPLC-DAD method was devel-oped and validated for the simultaneous quantification of 5-O-β-D-ga-lactopyranosyl-7-methoxy-3’,4’-dihydroxy-4-phenylcoumarin (4-PC) and its aglycone in rat feces. The 4-phenylcoumarins are important antidiabetic and gastroprotective bioactive metabolites of a highly commercialized medicinal plant complex in Mexico, the Copalchi complex. Both the sample preparation and the quantification method were developed; the methodology allows, for the first time ever, the simultaneous determination of the 4-PC (Rt= 2.4 min) and its metabo-lized aglycone (Rt= 7.5 min), aimed to their pharmacokinetic analysis, specially their elimination. Linearity was determined in the range, 0.09–4.5 µg/mL for both compounds (R2= 0.9999). Accuracy was <15.0% for 4-PC and aglycone with an interassay precision of maxi-mum %RSD of 6.1% for 4-PC and 2.7% for the aglycone. The intraassay precision was %RSD < 7.5 for 4-PC and < 3.5% for the aglycone. Analyte recovery from spiked samples was always > 98.02% for 4-PC and > 96.61% for its aglycone. The method was successfully applied to a single-dose preclinical pharmacokinetics preliminary study in rats.

Downloads

Download data is not yet available.

Author Biographies

Sol Cristians, Universidad Nacional Autónoma de México

Laboratorio de Etnobotánica, Jardín Botánico, Instituto de Biología.

Laboratorio 124, Departamento de Farmacia, Facultad de Química.

Kenneth Rubio-Carrasco, Universidad Nacional Autónoma de México

Laboratorio 113, Departamento de Farmacia, Facultad de Química.

Angélica Soledad Díaz-Juárez, Universidad Nacional Autónoma de México

Laboratorio 113, Departamento de Farmacia, Facultad de Química.

Vannesa González-Covarrubias, Instituto Nacional de Medicina Genómica

Laboratorio de Famacogenética

Inés Fuentes-Noriega, Universidad Nacional Autónoma de México

Laboratorio 113, Departamento de Farmacia, Facultad de Química.

References

Mociño, J.M. An. Hist. Nac. 1802, 3, 288-296.

Gentry, H.S. Río Mayo plants: a study of the flora and vegetation of the Valley of the Río Mayo, Sonora. Washington, Carnegie Insti-tution of Washington, 1942.

Díaz, J.L. Usos de las plantas medicinales de México: mono-grafías científicas I y II. México, Instituto Mexicano para el Estu-dio de las Plantas Medicinales, 1976.

Bye, R. Econ. Bot. 1986, 40, 103-124. DOI: https://doi.org/10.1007/BF02858951

Sahagún, B. Historia general de las cosas de Nueva España: pri-mera versión íntegra del texto castellano del manuscrito conocido como Códice Florentino (1540-1585). Madrid, Editorial Alianza, 1988.

Martínez, M. Las Plantas Medicinales de México. México, Edito-rial Botas, 1989.

Argueta, A.V.; Cano, L.M.; Rodarte, M.E. Atlas de las Plantas Medicinales de México. México, Instituto Nacional Indigenista, 1994.

Mata, R.; Cristians, S.; Escandón-Rivera, S.; Juárez-Reyes, K.; Rivero-Cruz, I. J. Nat. Prod. 2013; 76, 468-483. DOI: https://doi.org/10.1021/np300869g

Cristians, S.; Bye, R.; Navarrete, A; Mata, R. J. Ethnopharmacol. 2013, 145, 530-535. DOI: https://doi.org/10.1016/j.jep.2012.11.025

Reher, G.; Kraus, L. J. Nat. Prod. 1984, 47, 172-174. DOI: https://doi.org/10.1021/np50031a026

Reguero, M.T.; Mata, R.; Bye, R.; Linares, E.; Delgado, G. J. Nat. Prod. 1987, 50, 315-316. DOI: https://doi.org/10.1021/np50050a050

Mata, R.; Camacho, MR.; Cervera, E, Bye R, Linares E. Phyto-chemistry. 1990, 29, 2037-2040. DOI: https://doi.org/10.1016/0031-9422(90)85067-P

Mata, R.; Camacho, M. Del Rayo; Mendoza, S.; Cruz, M. Del Carmen. Phytochemistry. 1992, 31, 3199-31201. DOI: https://doi.org/10.1016/0031-9422(92)83474-D

Argotte-Ramos, R.; Ramírez-Ávila, G.; Rodríguez-Gutiérrez, M. C.; Ovilla-Muñoz, M.; Lanz-Mendoza, H.; Rodríguez, M.; González-Cortázar, M.; Alvarez, L. J. Nat. Prod. 2006, 69, 1442-1444 DOI: https://doi.org/10.1021/np060233p

Landa, E. An. Ins. Med. Nac. 1913, 12, 146-158.

Terres, J. An. Ins. Med. Nac. 1913, 12, 104-129. DOI: https://doi.org/10.1215/00382876-12-2-129

Guerrero-Analco, A.; Medina-Campos, O.; Brindis, F.; Bye, R.; Pedraza-Chaverri, J.; Navarrete, A.; Mata, R. Phytochemistry. 2007, 68, 2087-2095. DOI: https://doi.org/10.1016/j.phytochem.2007.05.006

Paris, R.R.; Bastien, M. Ann. Pharm. Franc. 1960, 18, 205-219. DOI: https://doi.org/10.1007/BF00316873

Pinto, A.; Capasso, A.; Sorrentino, L. Drug. Res. 1997, 47, 829-833.

Korec, R.; Heinz-Sensch, K.; Zoukas, T. Drug. Res. 2000, 50, DOI: https://doi.org/10.1016/S0168-8227(00)81600-9

-128.

Korecova, M.; Hladicova, M.; Korec, R. Z. Phytother. 2006, 27, DOI: https://doi.org/10.1055/s-2007-967719

-278.

Noster, S.; Kraus, L. Planta. Med. 1990, 56, 63-65. DOI: https://doi.org/10.1055/s-2006-960885

Rojas, A.; Hernández, L.; Pereda-Miranda, R.; Mata, R. J. Ethno-pharmacol. 1992, 35, 275-283. DOI: https://doi.org/10.1016/0378-8741(92)90025-M

Guerrero-Analco, J.A.; Hersch-Martínez, P.; Pedraza-Chaverri, A.; Navarrete, A.; Mata, R. Planta Med. 2005, 71, 1099-1105. DOI: https://doi.org/10.1055/s-2005-873137

Déciga-Campos, M.; Rivero-Cruz, I.; Arriaga-Alba, M.; Castañe-da-Corral, G.; Ángeles-López, G.E.; Navarrete, A.; Mata, R. J. Ethnopharmacol. 2007, 110, 334-342. DOI: https://doi.org/10.1016/j.jep.2006.10.001

Hernández-Ávila, M.; Gutierrez, J.P.; Encuesta Nacional de Salud y Nutrición. Evidencia para la política pública en salud. Diabetes Mellitus: La urgencia de reforzar la respuesta en políticas públi-cas para su prevención y control. México. Instituto Nacional de Salud Pública; 2012.

Mata, R.; Acevedo, L.; Méndez-Bautista, D.I.; Guerrero-Anal-co, J.A.; Rivero, B.E.; Rodríguez, J.M. Pharm. Biol. 2008, 46,105-116. DOI: https://doi.org/10.1080/13880200701734877

Cristians, S.; Guerrero-Analco, J.A.; Pérez-Vásquez, A.; Pala-cios-Espinosa, F.; Ciangherotti, C.; Bye, R.; Mata, R. J. Nat. Prod. 2009, 72, 408-413. DOI: https://doi.org/10.1021/np800642d

Pérez-Vásquez, A.; Castillejos-Ramírez, E.; Cristians, S.; Mata, R. J. Nat. Prod. 2014, 77, 516-520. DOI: https://doi.org/10.1021/np400785z

US Food Administration. Guidance for Industry: Bionalytical Method Validation. US Department of Health and Human Ser-vices, Food and Drug Administration, Center for Drug Evaluation and Research: Rockville, MD, 2001. Available from: http://www. fda/gov/dowlands/Drug/GuidanceComplianceRegulatoryInformation/Guidances/UCM070107.pdf

Secretaría de Salud. Norma Oficial Mexicana: NOM-177-SSA1-2013. Diario Oficial de la Federación, September 20th, 2013.

Viswanathan, C.T.; Bansal, S.; Booth, B.; De Stefano, A.J.; Rose, M.J.; Sailstad, J.; Shah, V.P.; Skelly, J.P.; Seann, P.G.; Weiner, R. Pharm. Res. 2007, 24, 1962-1973. DOI: https://doi.org/10.1007/s11095-007-9291-7

ICH. 2005. Harmonized tripartite guideline. Validation of ana-lytical procedures: text and methodology Q2 (R1). Available at: <http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1_Guide_line.pdf >

×

Downloads

Published

2017-10-12

Issue

Section

Regular Articles
x

Similar Articles

1 2 3 4 > >> 

You may also start an advanced similarity search for this article.

Loading...